Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas
- Status
- COMPLETED
- Phase
- PHASE2
Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type, ALK Negative Non Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Optimizing the Strategy for Preoperative Chemotherapy in Locally Advanced Gastric/Gastroesophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)
- Status
- COMPLETED
- Phase
- PHASE1
Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Definitive Therapy to Treat Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Chemotherapy Docetaxel With or Without SELUMETINIB in Patients With Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES)
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3